With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Artemether (Larither (1 ml)) is a potent and quick acting antimalarial agent,used for treating chloroquine resistant falciparum malaria,including cerebral malaria. The information provided on this ...

Review the side-effects of Artemether as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Due to stability concerns, the National Agency for Food and Drug Administration and Control (NAFDAC) has discontinued the registration of Multi-Dose Anti-Malarial ...

Kimberly E. Mace, Dyson Mwandama, James Jafali, Madalitso Luka, Scott J. Filler, John Sande, Doreen Ali, S. Patrick Kachur, Don P. Mathanga, Jacek Skarbinski https ...

First trial of its kind finds that treatment with triple artemisinin-based combination therapies (TACTs) is effective. TACTs were safe and well tolerated, but showed slightly higher rates of vomiting ...

Malaria treatment is recommended for patients with suspected Ebola virus disease (EVD) in West Africa, whether systematically or based on confirmed malaria diagnosis. At the Ebola treatment center in ...

Artemether/Lumefantrine (Coartem) Artemether/lumefantrine, locally known by the brand name Coartem, is the most common anti-malaria drug prescribed in Rwanda. Coartem is a first line, fixed-dose drug ...

Information regarding the safety and efficacy of artemisinin combination treatments for malaria in pregnant women is limited, particularly among women who live in sub-Saharan Africa. We conducted a ...

Roger Bate is a resident fellow at AEI. Richard Tren is the director of Africa Fighting Malaria. Kimberly Hess is a researcher at Africa Fighting Malaria. Amir Attaran is an associate professor and ...